Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
Annals of Clinical and Translational Neurology · 2023
DOI: 10.1002/acn3.51830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Layne N Rodden und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Neurology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, …. Hauptthemen laut MEDLINE: Friedreich Ataxia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Friedreich's Ataxia Research Alliance.
Abstract (Originalsprache)
Objective
Friedreich ataxia (FRDA) is an inherited condition caused by a GAA triplet repeat (GAA‐TR) expansion in the FXN gene. Clinical features of FRDA include ataxia, cardiomyopathy, and in some, vision loss. In this study, we characterize features of vision loss in a large cohort of adults and children with FRDA.
Methods
Using optical coherence tomography (OCT), we measured peripapillary retinal nerve fiber layer (RNFL) thickness in 198 people with FRDA, and 77 controls. Sloan letter charts were used to determine visual acuity. RNFL thickness and visual acuity were compared to measures of disease severity obtained from the Friedreich Ataxia Clinical Outcomes Measures Study (FACOMS).
Results
The majority of patients, including children, had pathologically thin RNFLs (mean = 73 ± 13 μm in FRDA; 98 ± 9 μm in controls) and low‐contrast vision deficits early in the disease course. Variability in RNFL thickness in FRDA (range: 36 to 107 μm) was best predicted by disease burden (GAA‐TR length X disease duration). Significant deficits in high‐contrast visual acuity were apparent in patients with an RNFL thickness of ≤68 μm. RNFL thickness decreased at a rate of −1.2 ± 1.4 μm/year and reached 68 μm at a disease burden of approximately 12,000 GAA years, equivalent to disease duration of 17 years for participants with 700 GAAs.
Interpretation
These data suggest that both hypoplasia and subsequent degeneration of the RNFL may be responsible for the optic nerve dysfunction in FRDA and support the development of a vision‐directed treatment for selected patients early in the disease to prevent RNFL loss from reaching the critical threshold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Pediatrics and Neurology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Clinical Data Science GmbH, Basel, Switzerland.
- Departments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Layne N Rodden, Christian Rummey, David R Lynch
Förderung
- Friedreich's Ataxia Research Alliance
Zitieren
APA
Rodden, L. N., McIntyre, K., Keita, M., Wells, M., Park, C., Profeta, V., Waldman, A., Rummey, C., Balcer, L. J., & Lynch, D. R. (2023). Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51830
Vancouver
Rodden LN, McIntyre K, Keita M, Wells M, Park C, Profeta V, et al. Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51830
BibTeX
@article{Rodden2023,
author = {Rodden, Layne N and McIntyre, Kellie and Keita, Medina and Wells, Mckenzie and Park, Courtney and Profeta, Victoria and Waldman, Amy and Rummey, Christian and Balcer, Laura J and Lynch, David R},
title = {Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
doi = {10.1002/acn3.51830}
}
EUVIMED